Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Cervical Cancer, May 2018

Free Subscription


Abstracts

Retrieve all available abstracts of the following 140 articles:
HTML format


 

Single Articles

  1. KALIFF M, Sorbe B, Mordhorst LB, Helenius G, et al
    Findings of multiple HPV genotypes in cervical carcinoma are associated with poor cancer-specific survival in a Swedish cohort of cervical cancer primarily treated with radiotherapy.
    Oncotarget. 2018;9:18786-18796.
    Abstract    

    Abstract available

  2. ZHOU YJ, Guo YJ, Yang XL, Ou ZL, et al
    Anti-Cervical Cancer Role of Matrine, Oxymatrine and Sophora Flavescens Alkaloid Gels and its Mechanism.
    J Cancer. 2018;9:1357-1364.
    Abstract    

    Abstract available

  3. FAN Y, Nan Y, Huang J, Zhong H, et al
    Up-regulation of inflammation-related LncRNA-IL7R predicts poor clinical outcome of patients with cervical cancer.
    Biosci Rep. 2018 May 2. pii: BSR20180483. doi: 10.1042/BSR20180483.
    Abstract    

    Abstract available

  4. MWAKA AD, Okello ES, Wabinga H
    Perceptions and beliefs of lay people from northern Uganda regarding surgery for diagnosis and treatment of cervical cancer.
    Psychooncology. 2018 May 2. doi: 10.1002/pon.4751.
    Abstract    

    Abstract available

  5. VRANIC S, Cyprian FS, Akhtar S, Al Moustafa AE, et al
    The Role of Epstein-Barr Virus in Cervical Cancer: A Brief Update.
    Front Oncol. 2018;8:113.
    Abstract    

    Abstract available

  6. GUZEL C, Govorukhina NI, Wisman GBA, Stingl C, et al
    Proteomic alterations in early stage cervical cancer.
    Oncotarget. 2018;9:18128-18147.
    Abstract    

    Abstract available

  7. SHAN D, Shang Y, Hu T
    MicroRNA-411 inhibits cervical cancer progression by directly targeting STAT3.
    Oncol Res. 2018 May 1. doi: 10.3727/096504018X15247361080118.
    Abstract    

    Abstract available

  8. VANAJA GR, Ramulu HG, Kalle AM
    Overexpressed HDAC8 in cervical cancer cells shows functional redundancy of tubulin deacetylation with HDAC6.
    Cell Commun Signal. 2018;16:20.
    Abstract    

    Abstract available

  9. LUO C, Liu M, Li X
    Efficacy and safety outcomes of robotic radical hysterectomy in Chinese older women with cervical cancer compared with laparoscopic radical hysterectomy.
    BMC Womens Health. 2018;18:61.
    Abstract    

    Abstract available

  10. HAQUE W, Verma V, Butler EB, Teh BS, et al
    Utilization of Hysterectomy Following Chemoradiation for IB2/IIA2 Cervical Cancer in the National Cancer Data Base.
    Anticancer Res. 2018;38:3175-3179.
    Abstract    

    Abstract available

  11. LIN CC, Kuo CL, Huang YP, Chen CY, et al
    Demethoxycurcumin Suppresses Migration and Invasion of Human Cervical Cancer HeLa Cells via Inhibition of NF-kappaB Pathways.
    Anticancer Res. 2018;38:2761-2769.
    Abstract    

    Abstract available

  12. LENO DWA, Diallo FD, Delamou A, Komano FD, et al
    Integration of Family Planning Counselling to Mass Screening Campaign for Cervical Cancer: Experience from Guinea.
    Obstet Gynecol Int. 2018;2018:3712948.
    Abstract    

    Abstract available

  13. HA IB, Jeong BK, Kang KM, Jeong H, et al
    Who Really Benefits from 3D-Based Planning of Brachytherapy for Cervical Cancer?
    J Korean Med Sci. 2018;33:e135.
    Abstract    

    Abstract available

  14. WANG S, Li J, Xie J, Liu F, et al
    Programmed death ligand 1 promotes lymph node metastasis and glucose metabolism in cervical cancer by activating integrin beta4/SNAI1/SIRT3 signaling pathway.
    Oncogene. 2018 Apr 30. pii: 10.1038/s41388-018-0252.
    Abstract    

    Abstract available

  15. PIBOONPRAI K, Khumkhrong P, Khongkow M, Yata T, et al
    Anticancer activity of arborinine from Glycosmis parva leaf extract in human cervical cancer cells.
    Biochem Biophys Res Commun. 2018 Apr 26. pii: S0006-291X(18)30968.
    Abstract    

    Abstract available

  16. ZHAO S, Francis L, Todor D, Fields EC, et al
    Proficiency-based cervical cancer brachytherapy training.
    Brachytherapy. 2018 Apr 25. pii: S1538-4721(18)30074.
    Abstract    

    Abstract available

  17. XIA C, Liang S, He Z, Zhu X, et al
    Metformin, a first-line drug for type 2 diabetes mellitus, disrupts the MALAT1/miR-142-3p sponge to decrease invasion and migration in cervical cancer cells.
    Eur J Pharmacol. 2018;830:59-67.
    Abstract    

    Abstract available

  18. ANDREASSEN T, Melnic A, Figueiredo R, Moen K, et al
    Attendance to cervical cancer screening among Roma and non-Roma women living in North-Western region of Romania.
    Int J Public Health. 2018 Apr 27. pii: 10.1007/s00038-018-1107.
    Abstract    

    Abstract available

  19. ZHU Y, Yang J, Zhang X, Chen D, et al
    Acquired treatment response from neoadjuvant chemotherapy predicts a favorable prognosis for local advanced cervical cancer: A meta-analysis.
    Medicine (Baltimore). 2018;97:e0530.
    Abstract    

    Abstract available

  20. SONG Y, Wang Q, Sui L, Gao SJ, et al
    [Clinical significance of loop electrosurgical excisional procedure in diagnosis and treatment of cervical adenocarcinoma in situ and invasive cervical adenocarcinoma].
    Zhonghua Fu Chan Ke Za Zhi. 2018;53:178-182.
    Abstract    

    Abstract available

  21. CHEN Q, Du H, Wang C, Tang JL, et al
    [Characteristics of invisible cervical intraepithelial neoplasia under colposcopy].
    Zhonghua Fu Chan Ke Za Zhi. 2018;53:172-177.
    Abstract    

    Abstract available

  22. TIAN T, Hua Z, Wang LZ, Wang XY, et al
    [S100A7 promotes the metastasis and epithelial-mesenchymal transition on HeLa and CaSki cells].
    Zhonghua Fu Chan Ke Za Zhi. 2018;53:99-105.
    Abstract    

    Abstract available

  23. BAO HL, Wang LH, Wang LM, Fang LW, et al
    [Study on the coverage of cervical and breast cancer screening among women aged 35-69 years and related impact of socioeconomic factors in China, 2013].
    Zhonghua Liu Xing Bing Xue Za Zhi. 2018;39:208-212.
    Abstract    

    Abstract available

  24. ZHONG J, Yuan H, Xu X, Kong S, et al
    MicroRNA195 inhibits cell proliferation, migration and invasion by targeting defective in cullin neddylation 1 domain containing 1 in cervical cancer.
    Int J Mol Med. 2018 May 8. doi: 10.3892/ijmm.2018.3660.
    Abstract    

    Abstract available

  25. ROA-DE LA CRUZ L, Martinez-Morales P, Moran-Cruz I, Milflores-Flores L, et al
    Expression analysis of ST3GAL4 transcripts in cervical cancer cells.
    Mol Med Rep. 2018 Apr 27. doi: 10.3892/mmr.2018.8938.
    Abstract    

    Abstract available

  26. JUAN C, Hua Q, Ruping Z, Tingting W, et al
    miRNA-489 as a biomarker in diagnosis and treatment of cervical cancer.
    Bratisl Lek Listy. 2018;119:278-283.
    Abstract    

    Abstract available

  27. SHEN J, Gao LL, Zhang Y, Han LL, et al
    [Prevalence of high-risk HPV and its distribution in cervical precancerous lesions among 35-64 years old women who received cervical cancer screening in Beijing].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2018;52:493-497.
    Abstract    

    Abstract available

  28. ZHANG KS, Liu Z, Wang T, Wang J, et al
    [Occurrence of radiation-induced injury in vagina after radical radiotherapy of cervical cancer and its affecting factors].
    Zhonghua Fu Chan Ke Za Zhi. 2018;53:257-262.
    Abstract    

    Abstract available

  29. HU J, Gao Y, Zheng Y, Shang X, et al
    KF-finder: identification of key factors from host-microbial networks in cervical cancer.
    BMC Syst Biol. 2018;12.
    Abstract    

    Abstract available

  30. KARAMANOU M, Markatos K, Laios K, Salakos N, et al
    The eminent gynaecologist Richard Wesley TeLinde (1894- 1989) and his contribution to diagnosis of cervical cancer.
    J BUON. 2018;23:537-540.
    Abstract    

    Abstract available

  31. LI Q, Wei X, Zhou ZW, Wang SN, et al
    GADD45alpha sensitizes cervical cancer cells to radiotherapy via increasing cytoplasmic APE1 level.
    Cell Death Dis. 2018;9:524.
    Abstract    

    Abstract available

  32. DYER C
    Irish woman is awarded euro2.5m from US laboratory that missed cervical cancer.
    BMJ. 2018;361:k2062.
    Abstract    



  33. CASTANEDA L, Bergmann A, Castro S, Koifman R, et al
    Functioning in Women with Cervical Cancer in Brazil: the Perspective of Experts.
    Rev Bras Ginecol Obstet. 2018 May 9. doi: 10.1055/s-0038-1646921.
    Abstract    

    Abstract available

  34. RENNA JUNIOR NL, Silva GAE
    Temporal trend and associated factors to advanced stage at diagnosis of cervical cancer: analysis of data from hospital based cancer registries in Brazil, 2000-2012.
    Epidemiol Serv Saude. 2018;27:e2017285.
    Abstract    

    Abstract available

  35. MARTH C, Landoni F, Mahner S, McCormack M, et al
    Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Ann Oncol. 2018 May 5. pii: 4993205. doi: 10.1093.
    Abstract    



  36. REN C, Wang H, Ding W, Gao C, et al
    Zinc Finger Nuclease Combines with Cisplatin and Trichostatin A Enhances the Antitumor Potency in Cervical Cancer Cells.
    Anticancer Agents Med Chem. 2018 May 9. pii: ACAMC-EPUB-90305.
    Abstract    

    Abstract available

  37. ARBYN M, Xu L, Simoens C, Martin-Hirsch PP, et al
    Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
    Cochrane Database Syst Rev. 2018;5:CD009069.
    Abstract    

    Abstract available

  38. GONG JM, Shen Y, Shan WW, He YX, et al
    The association between MTHFR polymorphism and cervical cancer.
    Sci Rep. 2018;8:7244.
    Abstract    

    Abstract available

  39. ZHANG J, Zhao X, Zhang J, Zheng X, et al
    Circular RNA hsa_circ_0023404 exerts an oncogenic role in cervical cancer through regulating miR-136/TFCP2/YAP pathway.
    Biochem Biophys Res Commun. 2018 May 5. pii: S0006-291X(18)31045.
    Abstract    

    Abstract available

  40. GAO C, Zhou C, Zhuang J, Liu L, et al
    MicroRNA expression in cervical cancer: Novel diagnostic and prognostic biomarkers.
    J Cell Biochem. 2018 May 8. doi: 10.1002/jcb.27029.
    Abstract    

    Abstract available

  41. WU XL, Guo T, Cai HW
    [Basic Research of the Adenovirus-mediated hCTR1 Transfection on the Treatment of Cisplatin Resistant Cervical Cancer].
    Sichuan Da Xue Xue Bao Yi Xue Ban. 2018;48:34-38.
    Abstract    

    Abstract available

  42. IFEDIORA CO, Azuike EC
    Knowledge and attitudes about cervical cancer and its prevention among female secondary school students in Nigeria.
    Trop Med Int Health. 2018 May 7. doi: 10.1111/tmi.13070.
    Abstract    

    Abstract available

  43. DAI L, Qiao J, Del Valle L, Qin Z, et al
    KSHV co-infection regulates HPV16+ cervical cancer cells pathogenesis in vitro and in vivo.
    Am J Cancer Res. 2018;8:708-714.
    Abstract    

    Abstract available

  44. TEOH D, Hultman G, DeKam M, Isaksson Vogel R, et al
    Excess Cost of Cervical Cancer Screening Beyond Recommended Screening Ages or After Hysterectomy in a Single Institution.
    J Low Genit Tract Dis. 2018 May 3. doi: 10.1097/LGT.0000000000000400.
    Abstract    

    Abstract available

  45. GAURI A, Messiah SE, Bouzoubaa LA, Moore KJ, et al
    Cervical cancer sociodemographic and diagnostic disparities in Florida: a population-based study (1981-2013) by stage at presentation.
    Ethn Health. 2018 May 5:1-9. doi: 10.1080/13557858.2018.1471669.
    Abstract    

    Abstract available

  46. COELHO A, Nogueira A, Soares S, Assis J, et al
    TP53 Arg72Pro polymorphism is associated with increased overall survival but not response to therapy in Portuguese/Caucasian patients with advanced cervical cancer.
    Oncol Lett. 2018;15:8165-8171.
    Abstract    

    Abstract available

  47. KORANEEKIT A, Limpaiboon T, Sangka A, Boonsiri P, et al
    Synergistic effects of cisplatin-caffeic acid induces apoptosis in human cervical cancer cells via the mitochondrial pathways.
    Oncol Lett. 2018;15:7397-7402.
    Abstract    

    Abstract available

  48. WANG L, Jiang MY, Qin Y, Li L, et al
    [Application of isothermal HPV DNA amplification test in cervical cancer screening].
    Zhonghua Zhong Liu Za Zhi. 2018;40:313-318.
    Abstract    

    Abstract available

  49. LIANG MR, Han DX, Jiang W, Liu H, et al
    [Laparoscopic type C1 hysterectomy based on the anatomic landmark of the uterus deep vein and its branches for cervical cancer].
    Zhonghua Zhong Liu Za Zhi. 2018;40:288-294.
    Abstract    

    Abstract available

  50. GU XY, Zheng RS, Sun KX, Zhang SW, et al
    [Incidence and mortality of cervical cancer in China, 2014].
    Zhonghua Zhong Liu Za Zhi. 2018;40:241-246.
    Abstract    

    Abstract available

  51. SABIK LM, Dahman B, Vichare A, Bradley CJ, et al
    Breast and Cervical Cancer Screening Among Medicaid Beneficiaries: The Role of Physician Payment and Managed Care.
    Med Care Res Rev. 2018 May 1:1077558718771123. doi: 10.1177/1077558718771123.
    Abstract    

    Abstract available

  52. CIBULA D, Potter R, Planchamp F, Avall-Lundqvist E, et al
    The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer.
    Virchows Arch. 2018 May 4. pii: 10.1007/s00428-018-2362.
    Abstract    

    Abstract available

  53. HUANG Y, Chen L, Guo A
    Upregulated expression of HOXC8 is associated with poor prognosis of cervical cancer.
    Oncol Lett. 2018;15:7291-7296.
    Abstract    

    Abstract available

  54. ISHIBASHI N, Maebayashi T, Aizawa T, Sakaguchi M, et al
    Brachytherapy for cervical cancer in septate uterus: Dose-volume differences with tandem implant placement in right vs. left uterine canal: A case report.
    Oncol Lett. 2018;15:7273-7278.
    Abstract    

    Abstract available

  55. RAMIREZ A, Vera E, Gamboa-Dominguez A, Lambert P, et al
    Calcium-activated potassium channels as potential early markers of human cervical cancer.
    Oncol Lett. 2018;15:7249-7254.
    Abstract    

    Abstract available

  56. LI L, Liu J, Liu C, Lu X, et al
    The correlation between TNF-alpha-308 gene polymorphism and susceptibility to cervical cancer.
    Oncol Lett. 2018;15:7163-7167.
    Abstract    

    Abstract available

  57. DONG SH, Wang X, Tian SC, Ma NQ, et al
    Arginine methyltransferase inhibitor 1 exhibits antitumor effects against cervical cancer in vitro and in vivo.
    Pharmazie. 2018;73:269-273.
    Abstract    

    Abstract available

  58. YOU D, Wang Y, Zhang Y, Li Q, et al
    Association of Foxp3 promoter polymorphisms with susceptibility to endometrial cancer in the Chinese Han women.
    Medicine (Baltimore). 2018;97:e0582.
    Abstract    

    Abstract available

  59. ARGYRI E, Tsimplaki E, Papatheodorou D, Daskalopoulou D, et al
    Recent Trends in HPV Infection and Type Distribution in Greece.
    Anticancer Res. 2018;38:3079-3084.
    Abstract    

    Abstract available

  60. HOLDENRIEDER S, Molina R, Qiu L, Zhi X, et al
    Technical and clinical performance of a new assay to detect squamous cell carcinoma antigen levels for the differential diagnosis of cervical, lung, and head and neck cancer.
    Tumour Biol. 2018;40:1010428318772202.
    Abstract    

    Abstract available

  61. SHARMA S, Munger K
    Expression of the cervical carcinoma expressed PCNA regulatory (CCEPR) long noncoding RNA is driven by the human papillomavirus E6 protein and modulates cell proliferation independent of PCNA.
    Virology. 2018;518:8-13.
    Abstract    

    Abstract available

  62. AUGUSTYNOWICZ A, Czerw A, Borowska M, Fronczak A, et al
    Breast cancer and cervical cancer prevention programmes carried out by local government units in Poland in 2009-2014.
    Oncotarget. 2018;9:21943-21949.
    Abstract    

    Abstract available

  63. CHECA-ROJAS A, Delgadillo-Silva LF, Velasco-Herrera MDC, Andrade-Dominguez A, et al
    GSTM3 and GSTP1: novel players driving tumor progression in cervical cancer.
    Oncotarget. 2018;9:21696-21714.
    Abstract    

    Abstract available

  64. SAMOUELIAN V, Mechtouf N, Leblanc E, Cardin GB, et al
    Sensitive molecular detection of small nodal metastasis in uterine cervical cancer using HPV16-E6/CK19/MUC1 cancer biomarkers.
    Oncotarget. 2018;9:21641-21654.
    Abstract    

    Abstract available

  65. RABELO-SANTOS SH, Termini L, Boccardo E, Derchain S, et al
    Strong SOD2 expression and HPV-16/18 positivity are independent events in cervical cancer.
    Oncotarget. 2018;9:21630-21640.
    Abstract    

    Abstract available

  66. KO HC, Huang JY, Miller JR, Das RK, et al
    Novel use of ViewRay MRI guidance for high-dose-rate brachytherapy in the treatment of cervical cancer.
    Brachytherapy. 2018 May 14. pii: S1538-4721(18)30147.
    Abstract    

    Abstract available

  67. LU XY, Chen M, Chen DH, Li Y, et al
    Remifentanil on T lymphocytes, cognitive function and inflammatory cytokines of patients undergoing radical surgery for cervical cancer.
    Eur Rev Med Pharmacol Sci. 2018;22:2854-2859.
    Abstract    

    Abstract available

  68. KIMMIG R, Ind T
    Minimally invasive surgery for cervical cancer: consequences for treatment after LACC Study.
    J Gynecol Oncol. 2018 May 14. pii: 29.e75. doi: 10.3802/jgo.2018.
    Abstract    



  69. KANAO H, Aoki Y, Takeshima N
    Unexpected result of minimally invasive surgery for cervical cancer.
    J Gynecol Oncol. 2018 May 15. pii: 29.e73. doi: 10.3802/jgo.2018.
    Abstract    



  70. LEE KB, Shim SH, Lee JM
    Comparison between adjuvant chemotherapy and adjuvant radiotherapy/chemoradiotherapy after radical surgery in patients with cervical cancer: a meta-analysis.
    J Gynecol Oncol. 2018 Apr 16. pii: 29.e62. doi: 10.3802/jgo.2018.
    Abstract    

    Abstract available

  71. SEOL HJ, Lee JM
    Rethinking surgical concepts for early cervical cancer.
    J Gynecol Oncol. 2018 Apr 3. pii: 29.e58. doi: 10.3802/jgo.2018.
    Abstract    



  72. THAPA N, Maharjan M, Petrini MA, Shah R, et al
    Knowledge, attitude, practice and barriers of cervical cancer screening among women living in mid-western rural, Nepal.
    J Gynecol Oncol. 2018 Apr 4. pii: 29.e57. doi: 10.3802/jgo.2018.
    Abstract    

    Abstract available

  73. GUNGORDUK K, Kocian R, Basaran D, Turan T, et al
    Are patients and physicians willing to accept less-radical procedures for cervical cancer?
    J Gynecol Oncol. 2018 Mar 12. pii: 29.e50. doi: 10.3802/jgo.2018.
    Abstract    

    Abstract available

  74. HARIPRASAD R, Mehrotra R
    Pocket colposcope: could it improve attendance and increase access to cervical cancer screening programmes?
    Expert Rev Anticancer Ther. 2018 May 16. doi: 10.1080/14737140.2018.1477592.
    Abstract    



  75. GUO H, Dai Y, Wang A, Wang C, et al
    Association between expression of MMP-7 and MMP-9 and pelvic lymph node and para-aortic lymph node metastasis in early cervical cancer.
    J Obstet Gynaecol Res. 2018 May 16. doi: 10.1111/jog.13659.
    Abstract    

    Abstract available

  76. LV XF, Hong HQ, Liu L, Cui SH, et al
    RNAimediated downregulation of asparaginaselike protein 1 inhibits growth and promotes apoptosis of human cervical cancer line SiHa.
    Mol Med Rep. 2018 May 14. doi: 10.3892/mmr.2018.9018.
    Abstract    

    Abstract available

  77. QIU F, Zhao X
    In vivo antitumor activity of liposomeplasmid DNA encoding mutant survivinT34A in cervical cancer.
    Mol Med Rep. 2018 May 11. doi: 10.3892/mmr.2018.9007.
    Abstract    

    Abstract available

  78. ZOLCIAK-SIWINSKA A, Kowalczyk A, Sikorska K, Bijok M, et al
    Comparison of computed tomography with magnetic resonance imaging for imaging-based clinical target volume contours in cervical cancer brachytherapy.
    Brachytherapy. 2018 May 12. pii: S1538-4721(18)30115.
    Abstract    

    Abstract available

  79. PAVALEANU I, Gafitanu D, Ioanid N, Grigore M, et al
    Preliminary results of the first cervical cancer screening programme in the North Eastern region of Romania.
    J Med Screen. 2018 Jan 1:969141317753462. doi: 10.1177/0969141317753462.
    Abstract    

    Abstract available

  80. BARNES A, Betts AC, Borton EK, Sanders JM, et al
    Cervical cancer screening among HIV infected women in an urban, U.S. safety-net healthcare system.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001881.
    Abstract    

    Abstract available

  81. LIU Y, Zhang Y, Cheng R, Liu S, et al
    Radiomics analysis of apparent diffusion coefficient in cervical cancer: A preliminary study on histological grade evaluation.
    J Magn Reson Imaging. 2018 May 14. doi: 10.1002/jmri.26192.
    Abstract    

    Abstract available

  82. XU F, Li Y, Fan L, Ma J, et al
    Preoperative SCC-Ag and thrombocytosis as predictive markers for pelvic lymphatic metastasis of squamous cervical cancer in early FIGO stage.
    J Cancer. 2018;9:1660-1666.
    Abstract    

    Abstract available

  83. DANG YZ, Li P, Li JP, Bai F, et al
    The Efficacy and Late Toxicities of Computed Tomography-based Brachytherapy with Intracavitary and Interstitial Technique in Advanced Cervical Cancer.
    J Cancer. 2018;9:1635-1641.
    Abstract    

    Abstract available

  84. MOLINA Y, San Miguel C, Sanz S, San Miguel L, et al
    Adapting to a Shifting Health Care Landscape: Illinois Breast and Cervical Cancer Program Lead Agencies' Perspectives.
    Health Promot Pract. 2018 May 1:1524839918776012. doi: 10.1177/1524839918776012.
    Abstract    

    Abstract available

  85. QIAN QP, Zhang X, Ding B, Jiang SW, et al
    Performance of P16/Ki67 dual staining in triaging hr-HPV-positive population during cervical Cancer screening in the younger women.
    Clin Chim Acta. 2018 May 11. pii: S0009-8981(18)30232.
    Abstract    

    Abstract available

  86. ZHU M, Feng M, He F, Han B, et al
    Pretreatment neutrophil-lymphocyte and platelet-lymphocyte ratio predict clinical outcome and prognosis for cervical Cancer.
    Clin Chim Acta. 2018 May 11. pii: S0009-8981(18)30234.
    Abstract    

    Abstract available

  87. CAPPIELLO JD, Boardman M
    Longitudinal study of advanced practice nurses' implementation of screening intervals for cervical cancer screening.
    J Am Assoc Nurse Pract. 2018;30:92-100.
    Abstract    

    Abstract available

  88. SULLIVAN T, Yacoub JH, Harkenrider MM, Small W Jr, et al
    Providing MR Imaging for Cervical Cancer Brachytherapy: Lessons for Radiologists.
    Radiographics. 2018;38:932-944.
    Abstract    

    Abstract available

  89. ZHU Y, Zhang G, Yang Y, Cui L, et al
    Perineural invasion in early-stage cervical cancer and its relevance following surgery.
    Oncol Lett. 2018;15:6555-6561.
    Abstract    

    Abstract available

  90. KIENEN N, Bittencourt L, Pelloso SM, Consolaro ME, et al
    Cervical Cancer Screening among Underscreened and Unscreened Brazilian Women: Training Community Health Workers to be Agents of Change.
    Prog Community Health Partnersh. 2018;12.
    Abstract    

    Abstract available

  91. FERRANDINA G, Palluzzi E, Gallotta V, Gambacorta MA, et al
    Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study.
    Eur J Surg Oncol. 2018 May 3. pii: S0748-7983(18)31025.
    Abstract    

    Abstract available

  92. KUMARI P, Rompicharla SVK, Muddineti OS, Ghosh B, et al
    Transferrin-anchored poly(lactide) micelles to improve anticancer activity of curcumin in hepatic and cervical cancer cell monolayers and 3D spheroids.
    Int J Biol Macromol. 2018 May 9. pii: S0141-8130(18)30629.
    Abstract    

    Abstract available

  93. WANG W, Zhang XH, Li M, Hao CH, et al
    Association between viral loads of different oncogenic human papillomavirus types and the degree of cervical lesions in the progression of cervical Cancer.
    Clin Chim Acta. 2018;483:249-255.
    Abstract    

    Abstract available

  94. LI ZH, Li L, Kang LP, Wang Y, et al
    MicroRNA-92a promotes tumor growth and suppresses immune function through activation of MAPK/ERK signaling pathway by inhibiting PTEN in mice bearing U14 cervical cancer.
    Cancer Med. 2018 May 11. doi: 10.1002/cam4.1329.
    Abstract    

    Abstract available

  95. HUO D, Anderson D, Herbst AL
    Follow-up of Patients with Clear-Cell Adenocarcinoma of the Vagina and Cervix.
    N Engl J Med. 2018;378:1746-1748.
    Abstract    



  96. GABRIELE V, Lecointre L, Faller E, Akladios C, et al
    Type B laparoscopic radical trachelectomy with uterine artery preservation for stage IB1 cervical cancer.
    J Minim Invasive Gynecol. 2018 May 21. pii: S1553-4650(18)30260.
    Abstract    



  97. JUN J
    Cancer/health communication and breast/cervical cancer screening among Asian Americans and five Asian ethnic groups.
    Ethn Health. 2018 May 23:1-22. doi: 10.1080/13557858.2018.1478952.
    Abstract    

    Abstract available

  98. SOUSA DMDN, Chagas ACMA, Vasconcelos CTM, Stein AT, et al
    Development of a clinical protocol for detection of cervical cancer precursor lesions.
    Rev Lat Am Enfermagem. 2018;26:e2999.
    Abstract    

    Abstract available

  99. CIBULA D, Potter R, Planchamp F, Avall-Lundqvist E, et al
    Correction to: The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer.
    Virchows Arch. 2018 May 23. pii: 10.1007/s00428-018-2380.
    Abstract    

    Abstract available

  100. FU F, Wang T, Wu Z, Feng Y, et al
    HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancer.
    Cell Death Dis. 2018;9:594.
    Abstract    

    Abstract available

  101. QIAO L, Zheng J, Tian Y, Zhang Q, et al
    Regulator of chromatin condensation 1 abrogates the G1 cell cycle checkpoint via Cdk1 in human papillomavirus E7-expressing epithelium and cervical cancer cells.
    Cell Death Dis. 2018;9:583.
    Abstract    

    Abstract available

  102. IBRAGIMOVA M, Tsyganov M, Shpileva O, Churuksaeva O, et al
    HPV status and its genomic integration affect survival of patients with cervical cancer.
    Neoplasma. 2018;65:441-448.
    Abstract    

    Abstract available

  103. POBIJAKOVA M, Scepanovic D, Paluga M, Fekete M, et al
    Dynamics of High Risk Clinical Target Volume reduction during Brachytherapy and impact on its coverage in patients with inoperable cervical cancer.
    Neoplasma. 2018;65:425-430.
    Abstract    

    Abstract available

  104. GONG M, Chen C, Zhao H, Sun M, et al
    miR-506 suppresses cervical cancer cell proliferation both in vitro and in vivo.
    Neoplasma. 2018;65:331-338.
    Abstract    

    Abstract available

  105. BERTA DF, Rocio LG, Silvia C, Susana M, et al
    Laparoscopic extraperitoneal pelvic lymph node debulking in locally advanced cervical cancer.
    J Minim Invasive Gynecol. 2018 May 18. pii: S1553-4650(18)30262.
    Abstract    

    Abstract available

  106. MANDERS DB, Sims TT, Bailey A, Hwang L, et al
    The Significance of Para-Aortic Nodal Size and the Role of Adjuvant Systemic Chemotherapy in Cervical Cancer: An Institutional Experience.
    Am J Clin Oncol. 2018 May 18. doi: 10.1097/COC.0000000000000458.
    Abstract    

    Abstract available

  107. PAREKH N, Donohue JM, Corbelli J, Men A, et al
    Screening for Sexually Transmitted Infections After Cervical Cancer Screening Guideline and Medicaid Policy Changes: A Population-Based Analysis.
    Med Care. 2018 May 17. doi: 10.1097/MLR.0000000000000925.
    Abstract    

    Abstract available

  108. OUH YT, Lee JK
    Proposal for cervical cancer screening in the era of HPV vaccination.
    Obstet Gynecol Sci. 2018;61:298-308.
    Abstract    

    Abstract available

  109. OAKLEY F, Desouki MM, Pemmaraju M, Gargano JM, et al
    Trends in High-Grade Cervical Cancer Precursors in the Human Papillomavirus Vaccine Era.
    Am J Prev Med. 2018 May 16. pii: S0749-3797(18)31672.
    Abstract    

    Abstract available

  110. GYULAI A, Nagy A, Pataki V, Tonte D, et al
    General practitioners can increase participation in cervical cancer screening - a model program in Hungary.
    BMC Fam Pract. 2018;19:67.
    Abstract    

    Abstract available

  111. KUDVA V, Prasad K, Guruvare S
    Andriod Device-Based Cervical Cancer Screening for Resource-Poor Settings.
    J Digit Imaging. 2018 May 18. pii: 10.1007/s10278-018-0083.
    Abstract    

    Abstract available

  112. CHHABRA R
    let-7i-5p, miR-181a-2-3p and EGF/PI3K/SOX2 axis coordinate to maintain cancer stem cell population in cervical cancer.
    Sci Rep. 2018;8:7840.
    Abstract    

    Abstract available

  113. FUMAGALLI I, Haie-Meder C, Chargari C
    3D brachytherapy for cervical cancer: New optimization ways.
    Cancer Radiother. 2018 May 15. pii: S1278-3218(18)30079.
    Abstract    

    Abstract available

  114. CHAUHAN SR, Bharadwaj M
    Gearing up T-cell immunotherapy in cervical cancer.
    Curr Probl Cancer. 2018 Apr 22. pii: S0147-0272(17)30200.
    Abstract    

    Abstract available

  115. KRAMER B, Kneissle M, Birk R, Rotter N, et al
    Tyrosine Kinase Inhibition in HPV-related Squamous Cell Carcinoma Reveals Beneficial Expression of cKIT and Src.
    Anticancer Res. 2018;38:2723-2731.
    Abstract    

    Abstract available

  116. BENNETT MH, Feldmeier J, Smee R, Milross C, et al
    Hyperbaric oxygenation for tumour sensitisation to radiotherapy.
    Cochrane Database Syst Rev. 2018;4:CD005007.
    Abstract    

    Abstract available

  117. LIANG Y, Li X, Wan H, Fang Y, et al
    Prognostic Value of Volume-Based Metabolic Parameters Obtained by 18F-FDG-PET/CT in Patients With Locally Advanced Squamous Cell Cervical Carcinoma.
    J Comput Assist Tomogr. 2018;42:429-434.
    Abstract    

    Abstract available

  118. MIN KJ, Lee JK, So KA, Kim MK, et al
    Association Between Passive Smoking and the Risk of Cervical Intraepithelial Neoplasia 1 in Korean Women.
    J Epidemiol. 2018;28:48-53.
    Abstract    

    Abstract available

  119. MAGALHAES JC, Azara CZS, Tavares SBDN, Manrique EJC, et al
    Impact of Implementing 100% Rapid Review as a Quality Control Tool in Cervical Cytology.
    Acta Cytol. 2018;62:115-120.
    Abstract    

    Abstract available

  120. QUEIROZ FILHO J, Eleuterio J Jr, Ney Cobucci R, de Oliveira Crispim JC, et al
    Does 100% Rapid Review Improve Cervical Cancer Screening?
    Acta Cytol. 2018 May 22:1-6. doi: 10.1159/000488872.
    Abstract    

    Abstract available

  121. KUROKAWA T, Onuma T, Shinagawa A, Chino Y, et al
    The Ideal Strategy for Cervical Cancer Screening in Japan: Result from the Fukui Cervical Cancer Screening Study.
    Cytopathology. 2018 May 16. doi: 10.1111/cyt.12576.
    Abstract    

    Abstract available

  122. VAN VELTHOVEN K, Poppe W, Verschuere H, Arbyn M, et al
    Pregnancy outcome after cervical conisation: A 2nd retrospective cohort study in the Leuven University Hospital.
    Eur J Obstet Gynecol Reprod Biol. 2017;216:224-231.
    Abstract    

    Abstract available

  123. MAYADEV J, Klapheke A, Yashar C, Hsu IC, et al
    Underutilization of brachytherapy and disparities in survival for patients with cervical cancer in California.
    Gynecol Oncol. 2018 Apr 27. pii: S0090-8258(18)30841.
    Abstract    

    Abstract available

  124. PHILP L, Jembere N, Wang L, Gao J, et al
    Pap tests in the diagnosis of cervical cancer: Help or hinder?
    Gynecol Oncol. 2018 May 15. pii: S0090-8258(18)30906.
    Abstract    

    Abstract available

  125. DAVIS M, Strickland K, Easter SR, Worley M Jr, et al
    The impact of health insurance status on the stage of cervical cancer diagnosis at a tertiary care center in Massachusetts.
    Gynecol Oncol. 2018 May 8. pii: S0090-8258(18)30887.
    Abstract    

    Abstract available

  126. TSENG JH, Aloisi A, Sonoda Y, Gardner GJ, et al
    Less versus more radical surgery in stage IB1 cervical cancer: A population-based study of long-term survival.
    Gynecol Oncol. 2018 May 15. pii: S0090-8258(18)30849.
    Abstract    

    Abstract available

  127. OLORUNFEMI G, Ndlovu N, Masukume G, Chikandiwa A, et al
    Temporal trends in the epidemiology of cervical cancer in South Africa (1994-2012).
    Int J Cancer. 2018 May 22. doi: 10.1002/ijc.31610.
    Abstract    

    Abstract available

  128. DRISCOLL SD, Tappen RM, Newman D, Voege-Harvey K, et al
    Accuracy of visual inspection performed by community health workers in cervical cancer screening.
    Int J Gynaecol Obstet. 2018 May 22. doi: 10.1002/ijgo.12535.
    Abstract    

    Abstract available

  129. TOMITA N, Mizuno M, Kondo S, Mori M, et al
    Role of Extensive Lymphadenectomy in Early-Stage Cervical Cancer Patients With Radical Hysterectomy Followed by Adjuvant Radiotherapy.
    Int J Gynecol Cancer. 2018 Apr 30. doi: 10.1097/IGC.0000000000001279.
    Abstract    

    Abstract available

  130. CORRADO G, Vizza E, Legge F, Pedone Anchora L, et al
    Comparison of Different Surgical Approaches for Stage IB1 Cervical Cancer Patients: A Multi-institution Study and a Review of the Literature.
    Int J Gynecol Cancer. 2018 Apr 30. doi: 10.1097/IGC.0000000000001254.
    Abstract    

    Abstract available

  131. KOCAER M, Gulseren V, Ozdemir IA, Gungorduk O, et al
    Management of Vertebral Metastasis in Patients With Uterine Cervical Cancer.
    Int J Gynecol Cancer. 2018 May 4. doi: 10.1097/IGC.0000000000001273.
    Abstract    

    Abstract available

  132. JALLOUL RJ, Sharma S, Tung CS, O'Donnell B, et al
    Pattern of Care, Health Care Disparities, and Their Impact on Survival Outcomes in Stage IVB Cervical Cancer: A Nationwide Retrospective Cohort Study.
    Int J Gynecol Cancer. 2018 May 4. doi: 10.1097/IGC.0000000000001264.
    Abstract    

    Abstract available

  133. KRANAWETTER M, Rohrich S, Mullauer L, Obermair H, et al
    Activity of Pembrolizumab in Recurrent Cervical Cancer: Case Series and Review of Published Data.
    Int J Gynecol Cancer. 2018 May 22. doi: 10.1097/IGC.0000000000001291.
    Abstract    

    Abstract available

  134. CUI RR, Chen L, Tergas AI, Hou JY, et al
    Trends in Use and Survival Associated With Fertility-Sparing Trachelectomy for Young Women With Early-Stage Cervical Cancer.
    Obstet Gynecol. 2018 May 7. doi: 10.1097/AOG.0000000000002613.
    Abstract    

    Abstract available

  135. CIBULA D, Potter R, Planchamp F, Avall-Lundqvist E, et al
    The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer.
    Radiother Oncol. 2018 Apr 12. pii: S0167-8140(18)30135.
    Abstract    

    Abstract available

  136. FOKDAL L, Potter R, Kirchheiner K, Lindegaard JC, et al
    Physician assessed and patient reported urinary morbidity after radio-chemotherapy and image guided adaptive brachytherapy for locally advanced cervical cancer.
    Radiother Oncol. 2018 May 18. pii: S0167-8140(18)30242.
    Abstract    

    Abstract available

  137. MABELELE MM, Materu J, Ng'ida FD, Mahande MJ, et al
    Knowledge towards cervical cancer prevention and screening practices among women who attended reproductive and child health clinic at Magu district hospital, Lake Zone Tanzania: a cross-sectional study.
    BMC Cancer. 2018;18:565.
    Abstract    

    Abstract available

  138. DIAZ A, Baade PD, Valery PC, Whop LJ, et al
    Comorbidity and cervical cancer survival of Indigenous and non-Indigenous Australian women: A semi-national registry-based cohort study (2003-2012).
    PLoS One. 2018;13:e0196764.
    Abstract    

    Abstract available

  139. LIU S, Minaguchi T, Lachkar B, Zhang S, et al
    Separate analysis of human papillomavirus E6 and E7 messenger RNAs to predict cervical neoplasia progression.
    PLoS One. 2018;13:e0193061.
    Abstract    

    Abstract available

  140. GRANDAHL M, Chun Paek S, Grisurapong S, Sherer P, et al
    Parents' knowledge, beliefs, and acceptance of the HPV vaccination in relation to their socio-demographics and religious beliefs: A cross-sectional study in Thailand.
    PLoS One. 2018;13:e0193054.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;